We have a strong track record in developing, testing and validating innovations for health that save lives. Our mission is to improve people’s health and wellbeing through research, training and services.
Our Contribution to New Knowledge in Public Health
Each year, our scientists publish over 100 articles in international journals
Published on: May 30, 2023
Burden of HIV and treatment outcomes among TB patients in rural Kenya: a 9-year longitudinal study.
Published on: May 30, 2023
Corrigendum to "Persistently high proportions of plasmodium-infected Anopheles funestus mosquitoes in two villages in the Kilombero valley, South-Eastern Tanzania"
Published on: May 30, 2023
Acceptability and uptake of oral HIV self-testing among rural community members in Tanzania: a pilot study.
IHI Data Repository
Our Data Repository provides information from hundreds of our past projects that can be useful for research, training, policy and action.
Ifakara Hub
A vibrant community of inspiration, ideation and collaboration for solution development
ISO 9001: 2015
Since 2018, our management system has been certified as ISO 9001: 2015 compliant
Our accredited Masters program
We offer a unique accredited Masters of Science in Public Health Research (MScPHR) in collaboration with the Nelson Mandela African Institution for Science and Technology. We have a dedicated Training Center for the program in Bagamoyo, Tanzania.
Our ISO 15189:2012 Accredited Labs
Our BSL II labs in Bagamoyo have been accredited as ISO 15189:2012 compliant by the Southern African Development Community Accreditation Service (SADCAS).
Our Projects
We have over sixty active projects.
A randomised, controlled clinical trial to assess and compare the immunogenicity, safety and reactogenicity of the bivalent Omicron BA.4/BA.5 adapted, and the original Wuhan-Hu-1-strain, BNT162b2 COVID-19 Vaccine formulations in healthy unvaccinated East African adults
The project title is “A randomized, controlled clinical trial to assess and compare the immunogenicity, safety and reactogenicity of a bivalent Omicron BA.4/BA.5 adapted, and the original Wuhan-Hu-1-strain, BNT162b2 COVID-19 vaccine formulations in healthy unva…
Strengthening health systems to establish a care of chain and referral for management of NCDs in hard to reach populations of Tanzania
This project aims to tackle the high burden of Non-communicable diseases (NCDs) that are currently affecting a large population of the world.
According to the World Health Organization (WHO), NCDs cause approximately 41 m…
MAMS STEP2C: A multiple arm, multiple stage (MAMS) PHASE 2b/c, Open Label, randomized controlled platform trial to evaluate experimental arms
The project is titled “A multiple arms, multiple stages (MAMS) PHASE 2b/c, Open Label, randomized controlled platform trial to evaluate experimental arms including an increased dose of rifampicin, an optimized dose of pyrazinamide, moxifloxacin, and sutezolid, …
DIRECTOR'S MESSAGE
Welcome aboard!
I welcome you to learn about IHI.
We’re influencing policy; taking science to the public; and optimistic about the future
DIRECTOR'S MESSAGE
Welcome aboard!
We’re influencing policy; taking science to the public; and optimistic about the future.
Top News
All News
Ifakara Health Institute senior research scientist, Dr. Esther Elisaria, is a member of the presidential national tas…
June 5, 2023
Research led by Ifakara Health Institute scientists has confirmed the efficacy of another malaria vaccine. The vaccin…
June 2, 2023
"MTAFITI" - the monthly news and events round-up of Ifakara Health Institute - May 2023 edition is out. The…
June 1, 2023Top Event
All Events
WORKSHOP: Ifakara’s Data Science team sharpens paper writing skills
April 28, 2023, 9:00hrs
TRAINING: Ifakara Innovation Hub capacitates startups with quality management system procedures
May 15, 2023, 9:00hrs
ENGAGEMENT: Ifakara showcases research work at Uhuru Torch event
May 9, 2023, 02:00